Helius Therapeutics cultivates, researches, and manufactures medicinal cannabis products.
Helius Therapeutics has raised $57K in total funding. The most recent round was Grant. The last funding was announced in May 2024.
Helius Therapeutics's investors include Callaghan Innovation.
Helius Therapeutics is headquartered in East Tamaki, New Zealand.
Helius Therapeutics cultivates, researches, and manufactures medicinal cannabis products.
Helius Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Helius Therapeutics — Funding & Investors." VCBacked, May 20, 2024, https://www.vcbacked.co/company/helius-therapeutics. Accessed July 20, 2026.
VCBacked. (2024). Helius Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/helius-therapeutics
{{cite web |title=Helius Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/helius-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated